Clinical Trial Update: Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of combining saxagliptin with dapagliflozin on islet cell function in adults with type 2 diabetes; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Onglyza (Saxagliptin)

Snippet

Sponsor: Prof. Dr. Thomas Forst | Conditions: Type2 Diabetes Mellitus | Phase 4 | Status: COMPLETED